Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, grantg2, Big_Money_Upward
Search This Board:
Last Post: 11/25/2014 11:07:25 PM - Followers: 288 - Board type: Free - Posts Today: 0
NYSE now, upgraded from OTC!    

This company is 3D bioprinting. That means working towards printing human organs, using stems cells and such as ink.     


 As of Thu, Jul 11, 2013, ONVO trades on NYSE Amex. 

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.

ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit


Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.



World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  

   Organovo Support Chart

NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Current Report Filing (8-k) 11/25/2014 05:27:49 PM
ONVO News: Organovo to Present at the 26th Annual Piper Jaffray Healthcare Conference 11/20/2014 08:05:00 AM
ONVO News: Organovo Announces Commercial Release of the exVive3D™ Human Liver Tissue 11/18/2014 08:05:00 AM
ONVO News: Current Report Filing (8-k) 11/10/2014 04:07:13 PM
ONVO News: Organovo Holdings, Inc. Reports Second Quarter Results 11/10/2014 08:00:00 AM
News News Alert: Current Report Filing (8-k) 11/25/2014 05:27:49 PM
#7214  Sticky Note Article today on CNN money shorty355 11/04/14 10:44:51 AM
#6278  Sticky Note ONVO news: "Organovo Reports Positive Results from a rayank 06/26/14 10:25:47 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#7388   Just getting warmed up... Here is something from RandolRocketman 11/25/14 11:07:25 PM
#7387   You are catching on. Shorts are desperate and dshade 11/25/14 09:19:52 PM
#7386   There's that clear buy signal here again. Once RandolRocketman 11/25/14 03:27:13 PM
#7385   M&A story here is not happening, and obviously adeezl 11/25/14 02:50:17 PM
#7384   Yes, and I still own shares from when chaostrader 11/25/14 02:39:35 PM
#7383   It's a much better short. I short this adeezl 11/25/14 02:19:08 PM
#7382   only 1000 shares at big deal. Alvie 11/24/14 06:51:38 PM
#7381   whoa $6.72 AH chaostrader 11/24/14 04:21:42 PM
#7380   Love ONVO. Bought 10K shares at the close chaostrader 11/24/14 12:03:30 PM
#7379   Smooth sailing HennHouse 11/24/14 11:55:41 AM
#7378   Just fine. dshade 11/24/14 11:48:10 AM
#7377   Well let's see how ONVO holds up now HennHouse 11/24/14 09:29:18 AM
#7375   The press release about the ExVive3D commercial release WinnerAlright 11/23/14 08:12:41 PM
#7374   Harsh...he said he was taking a 40% hit hogfan2 11/23/14 07:52:22 AM
#7373   Or did he? In all seriousness, holding sbkeep 11/22/14 12:00:53 PM
#7372   Congrats on being impatient and selling at a low HennHouse 11/21/14 04:04:32 PM
#7371   Just took my final decision and sold now, moustaf911 11/21/14 01:52:42 PM
#7370   I don't have much but I think this RallyTheMarket 11/21/14 01:35:44 PM
#7369   Engadget just posted an article on ONVO liver RallyTheMarket 11/21/14 01:25:53 PM
#7368 HennHouse 11/21/14 08:23:39 AM
#7367   ditto rallythemarket...i swing trade this and am currently hogfan2 11/20/14 07:41:43 PM
#7366   News takes time. If this were some big RallyTheMarket 11/20/14 04:33:30 PM
#7365   No i didn't sell yet but my plan moustaf911 11/20/14 04:23:47 PM
#7364   Hey so did you sell today? Good luck RallyTheMarket 11/20/14 03:52:41 PM
#7363 lnong 11/20/14 02:52:28 PM
#7362 72vett 11/20/14 09:12:01 AM
#7361 72vett 11/20/14 09:10:39 AM
#7360   To be fair the news could still need RallyTheMarket 11/19/14 04:40:25 PM
#7356   Now_we're_waiting_on_Revenue After_that_it'll_be_dog_and_a_Pony rumper 11/19/14 02:59:49 PM
#7355   Guys i don't wanna be negative here but moustaf911 11/19/14 02:48:31 PM
#7354   Yes I see there are companies in 3d WinnerAlright 11/19/14 02:19:20 PM
#7353   See previous post and add.... they have no dshade 11/19/14 02:13:35 PM
#7352   Relax and just buy when you cann. Trade dshade 11/19/14 02:11:49 PM
#7351   Yes but what about competitors that aren't publicly WinnerAlright 11/19/14 02:09:32 PM
#7350   ONVO is the only publicly traded company in Big_Money_Upward 11/19/14 02:04:33 PM
#7349   ONVO is being buried by the shorts rumper 11/19/14 12:22:31 PM
#7348   Does anybody know if there are other companies WinnerAlright 11/19/14 10:51:50 AM
#7347 Big_Money_Upward 11/19/14 09:28:04 AM
#7346   the writer Jerome Groopman probably wrote the medical chaostrader 11/18/14 11:30:29 PM
#7345   Wouldn't want to hold this short as deals HennHouse 11/18/14 11:02:50 PM
#7344   I find it funny given todays news for ONVO manfromjax 11/18/14 07:37:42 PM
#7343   Keith Murphy Interview...2 weeks ago... hogfan2 11/18/14 04:44:49 PM
#7342 The exVive3D™ Liv hogfan2 11/18/14 04:39:45 PM
#7341 hogfan2 11/18/14 04:37:34 PM
#7340 hogfan2 11/18/14 04:36:14 PM
#7339   agreed...ONVO hit the 100 day ma and settled hogfan2 11/18/14 04:25:49 PM
#7338   so rumper did you convince the 2 guys hogfan2 11/18/14 04:20:35 PM
#7337   No new high, no meaningful volume, still_in_a_downtrend rumper 11/18/14 03:00:09 PM
#7336   The street buys what the analysts say to buy. Mister Dude 11/18/14 02:50:19 PM
#7335   For me its about the company. ONVO is chaostrader 11/18/14 02:08:21 PM